Prospective brain imaging evaluation of children with sickle cell trait: Initial observations

Radiology

Volumn 228, Issue 1, 2003, Pages 208-215

  Steen, R Grant ^a,b   Hankins, Gisele M ^a   Xiong, Xiaoping ^a   Wang, Winfred C ^a,b   Beil, Kenneth ^a   Langston, James W ^a,b   Helton, Kathleen J ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Brain, MR; Cerebral angiography; Children, central nervous system Magnetic resonance (MR), vascular studies; Sickle cell disease (SS, SC)

Indexed keywords

HEMOGLOBIN S;

ADOLESCENT; ARTERY OCCLUSION; ARTICLE; BRAIN DISEASE; BRAIN MAPPING; BRAIN SIZE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENCEPHALOMALACIA; FEMALE; HUMAN; LEUKOENCEPHALOPATHY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEGRO; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SICKLE CELL TRAIT; STROKE; VASCULAR DISEASE; WHITE MATTER;

ADOLESCENT; BRAIN; CHILD; FEMALE; HEMOGLOBIN A; HEMOGLOBIN, SICKLE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; SICKLE CELL TRAIT;

EID: 0038037816     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2281020600     Document Type: Article

References (57)

1. Wood DH. Cerebrovascular complications of sickle cell anemia. Stroke 1975; 12:23-27.
2. Powars DR, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med 1978; 65:461-471.
3. Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. Semin Hematol 1991; 28:213-219.
4. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickJe cell disease. J Pediatr 1992; 120:360-366.
5. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994; 330:1639-1644.
6. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997; 42:699-704.
7. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91:288-294.
8. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998; 51:169-176.
9. Thompson RK, Wagner SA, Maclead M. Sickle cell disease: report of a case with cerebral manifestations in the absence of anemia. Ann Intern Med 1948; 29:921-928.
10. Diggs LW, Jones RS. Clinicopathologic conference. Am J Clin Pathol 1952; 22:1194-1200.
11. Ende N, Pizzolato P, Ziskind J. Sicklemia. Ann Intern Med 1955; 42:1065-1075.
12. Ober WB, Bruno MS, Weinberg SB, Jones FM, Weiner L. Fatal intravascular sickling in a patient with sickle-cell trait. N Engl J Med 1960; 263:947-949.
13. McCormick WF. Abnormal hemoglobins. 11. The pathology of sickle cell trait. Am J Med Sci 1961; 241:329-335.
14. Greer M, Schotland D. Abnormal hemoglobin as a cause of neurologic disease. Neurology 1962; 12:114-123.
15. Schenk EA. Sickle cell trait and superior longitudinal sinus thrombosis. Ann Intern Med 1964; 60:465-470.
16. Portnoy BA, Herion JC. Neurological manifestations in sickle-cell disease with a review of the literature and emphasis on the prevalence of hemiplegia. Ann Intern Med 1972; 76:643-652.
17. Dalal FX, Schmidt GB, Bennett EJ, Ramamorthy S. Sickle cell trait: a report of a postoperative neurologic complication. Br J Anaesth 1974; 46:387-388.
18. Pensider MI, Radke JR. ARDS and cerebral infarction complicating Mycoplasma pneumonia in sickle cell trait. Henry Ford Hosp Med J 1980; 28:60-62.
19. Handler CE, Perkins GD. Sickle cell trait and multiple cerebral lnfarctions. J R Soc Med 1982; 75:550-553.
20. Greenberg J, Massey EW. Cerebral infarction in sickle cell trait. Ann Neurol 1985; 18:354-355.
21. Reyes MG. Subcortical cerebral infarction in sickle cell trait. J Neurol Neurosurg Psychiatry 1989; 52:516-518.
22. Pavlakis SG, Prohovnik I, Plomelli S, DeVivo DC. Neurologic complications of sickle cell disease. Adv Pediatr 1989; 36:247-276.
23. Radhakrishnan K, Thacker AK, Maloo JC, El-Mangoush MA. Sickle cell trait and stroke in the young adult. Postgrad Med J 1990; 66:1078-1080.
24. Hart RG, Kanter MC. Hematologic disorders and ischemic stroke: a selective review. Stroke 1990; 21:1111-1121.
25. Partington MD, Aronyk KE, Byrd SE. Sickle cell trait and stroke in children. Pediatr Neurosurg 1994; 20:148-151.
26. Gines R, Truemper E. Stroke in a 9-year-old with sickle cell trait (letter). Am J Emerg Med 1998; 16:104-105.
27. Sears DA. The morbidity of sickle cell trait: a review of the literature. Am J Med 1978; 64:1021-1036.
28. Steen RG, Langston JW, Ogg RJ, Manci E, Mulhern RK, Wang W. Ectasia of the basilar artery in children with sickle cell disease: relationship to hematocrit and psychometric measures. J Stroke Cerebrovasc Dis 1998; 7:32-43.
29. Steen RG, Reddick WE, Glass J, Wang W. Evidence of cranial artery ectasia in sickle cell disease patients with ectasia of the basilar artery. J Stroke Cerebrovasc Dis 1998; 7:330-338.
30. Steen RG, Helton KJ, Horwitz EM, et al. Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Ann Neurol 2001; 49:222-229.
31. U.S. Census Bureau. American Fact-Finder. Available at: factfinder.census.gov. Accessed April 2002.
32. Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black patients. N Engl J Med 1979; 300:1001-1005.
33. Hampton ML, Anderson J, Lavizzo BS, Bergman AB. Sickle cell "nondisease": a potentially serious public health prob-lem. Am J Dis Child 1974; 128:58-61.
34. Wang W, Enos L, Gallagher D, et al. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001; 139:391-397.
35. Miller ST, Macklin EA, Pegelow CH, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001; 139:385-390.
36. Moser DF, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol 1996; 17:965-972.
37. Barkovich AJ. Pediatric Neuroimaging. 3rd ed. New York, NY: Lippincott, Williams & Wilkins, 2000; 41.
38. Reddick WE, Glass JO, Langston JW, Helton KJ. Quantitative MRI assessment of leukoencephalopathy. Magn Reson Med 2002; 47:912-920.
39. Diggs LW, Ahmann DF, Bibb J. The inddence and significance of the sickle cell trait. Ann Intern Med 1933; 7:769-776.
40. Ashcroft MT, Miall WE, Milner PF. A comparison between the characteristics of Jamaican adults with normal hemoglobin and those with sickle cell trait. Am J Epidemiol 1969; 90:236-243.
41. Polednak AP, Janerich DT. Hematocrit among blacks with sickle cell trait. Hum Biol 1975; 47:493-504.
42. Yip R, Nelson PE. Hemoglobin concentration of children with sickle cell trait. J Pediatr 1981; 99:257-258.
43. Rana SR, Seksaria S, Castro OL. Hemoglobin S and C traits: contributing causes for decreased mean hematocrit in African-American children. Pediatrics 1993; 91:800-802.
44. Needleman HL, Shell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to low doses of lead in childhood: an 11-year follow-up report. N Engl J Med 1990; 311:83-88.
45. Siekert RG, Whisnant JP, Millikan CH. Anemia and intermittent focal cerebral arterial insufficiency. Arch Neurol 1960; 3:386-390.
46. Jones SR, Binder RA, Donowho EM Jr. Sudden death in sickle-cell trait. N Engl J Med 1970; 282:323-325.
47. Platt HS. Effect of maternal sickle-cell trait on perinatal mortality. BMJ 1971; 1:334-336.
48. Sullivan LW. The risks of sickle-cell trait: caution and common sense. N Engl J Med 1987; 317:830-831.
49. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 1987; 317:781-787.
50. Neuhauser KM, Neuhauser TS, Drehner D, Blackwood GV. Death among U.S. Air Force basic trainees, 1956 to 1996. Mil Med 1999; 164:841-847.
51. Boyle E, Thompson C, Tyroler HA. Prevalence of the sickle cell trait in adults of Charleston County, SC. Arch Environ Health 1968; 17:891-898.
52. Lannuzel A, Salmon V, Mevel G, Malpote E, Rabier R, Capairos-Lefebvre D. Epidemiology of stroke in Guadeloupe and role of sickle cell trait. Rev Neurol (Paris) 1999; 155:351-356. [French]
53. Friday G, Lai SM, Alter M, et al. Stroke in the Lehigh Valley: racial/ethnic differences. Neurology 1989; 39:1165-1168.
54. Kittner SJ, McCarter RJ, Sherwin RW, et al. Black-white differences in stroke risk among young adults. Stroke 1993; 23(12 suppl):113-115.
55. Gaines K, Burke G. Ethnic differences in stroke: black-white differences in the United States population: SECORDS investigators - Southeastern Consortium on Racial Differences in Stroke. Neuroepidemiology 1995; 14:209-239.
56. Beutler E, Boggs DR, Heller P, Maurer A, Motulsky AG, Sheehy TW. Hazards of indiscriminate screening for sickling. N Engl J Med 1971; 285:1485-1486.
57. Motulsky AG. Riskin sickle-cell trait. Ann Intern Med 1973; 78:613-614.